For decades, checking blood sugar meant the same routine: a lancet, a test strip, a drop of blood, and a number that told you ...
The Non-Insured Health Benefits (NIHB) program establishes exemplary coverage for Dexcom’s real-time continuous glucose monitoring system – bringing game-changing technology to more First Nations and ...
Health tech startup Signos announced a $20 million funding round Wednesday, including an expanded partnership with medical ...
SAN DIEGO--(BUSINESS WIRE)-- Dexcom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today its next-generation Dexcom G7 CGM System ...
Glucose monitoring specialist Dexcom announced it received FDA clearance for its G7 15 Day continuous glucose monitoring (CGM) system for people 18 and older with type 1, type 2 and gestational ...
In 2022, Dexcom began rolling out in Europe the Dexcom One system, a straightforward continuous glucose monitoring setup that stripped away some of the bells and whistles of its flagship G-series CGMs ...
Diabeloop, a pioneer in therapeutic artificial intelligence for diabetes management, today announced technical ...
DexCom DXCM recently announced the launch of Dexcom Flex, a new continuous glucose monitoring (CGM) system designed for ...
Signos Inc., the company behind the first FDA-cleared, over-the-counter glucose monitoring system for weight management, today announced a $20 million funding round with investment from GV (Google ...